Presence of significantly high levels of IL-32 in synovial tissue biopsies of RA as compared to its absence in osteoarthritic (OA) patients confirmed that IL-32 is potent mediator of the active osteoclastogenic activity [22]. This evidence concerns the gene IL32 and rheumatoid arthritis.